Purchase 4,4-DMAR
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 4,4-DMAR for sale
4,4'-DMAR is a designer drug that acts as a psychostimulant and entactogen. It was first detected in the Netherlands and is sold around Europe as a designer drug. 4,4'-DMAR had been linked to at least 31 deaths in Hungary and Poland by February 2014, mainly when consumed with other drugs.
4,4'-Dimethylaminorex (abbreviated as 4,4'-DMAR), sometimes referred to by the street name "Serotonin," is a psychostimulant and entactogen designer drug related to aminorex, 4-methylaminorex, and pemoline. It was first detected in the Netherlands in December 2012 and sold as a designer drug around Europe since mid-2013.
4,4'-Dimethylaminorex (abbreviated as 4,4'-DMAR) is a psychostimulant and entactogen designer drug related to aminorex, 4-methylaminorex and pemoline. It was first detected in the Netherlands in December 2012 and sold as a designer drug around Europe since mid-2013.
4,4'-dimethylaminorex, more commonly referred to as 4,4-'DMAR', is a psychostimulant and entactogen, closely related to aminorex, 4-methylaminorex and pemoline. It was first discovered in the Netherlands in December 2012 and sold as a designer drug across Europe since mid-2013.
4,4'-Dimethylaminorex is a new psychoactive substance (NPS) with stimulant and entactogenic properties. It was first detected in the Netherlands in December 2012 and sold as a designer drug around Europe since mid-2013.
4,4'-DMAR is a designer drug that contains m-methoxy groups on the amine (NH2) groups of the two-ring benzene structure and a pipeline ring at the 4-position of the 4-methylamino group.
4,4'-Dimethylaminorex is a chemical related to aminorex, 4-methylaminorex and pemoline. It binds to monoamine transporter and dopamine reuptake sites.
4,4'-DMAR is a stimulating substance and has been found in powders in several countries across Europe.
4,4'-DMAR is a psychostimulant and entactogen designer drug related to aminorex, 4-methylaminorex, and pemoline. It was first detected in the Netherlands in December 2012 and sold as a designer drug around Europe since mid-2013.
4,4'-DMAR is an organic compound used as a psychostimulant and entactogen. Clandestine production of this drug started in 2012, and since mid-2013, it has appeared on the recreational drug market in Europe and around twenty other countries.
4,4-DMAR is a new designer stimulant, and the entactogen series detected in different products reported to have been consumed by 19 people since July 2014 in the Netherlands.
4,4'-DMAR is an entactogenic chemical from within the class of psychostimulants. It is also a powerful stimulant with a high addictive potential.
4,4'-DMAR is a classification of an entactogen and psychostimulant that produces empathogenic and stimulant effects when administered.
4,4'- DMAR is a designer psychostimulant with effects similar to amphetamines and other serotonin-releasing agents. It is known for its capacity to cause hallucinations, delirium and mania.
4,4'-DMAR is a psychostimulant of the phenethylamine and amphetamine chemical classes. It produces its psychoactive effects through increased dopamine levels in the brain.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics